LOL, complete bullshit. The MHRA disagrees as they just designed 2 pediatric trials using the same ECA methodology as was used in the DCVax-L adult trial.
Ace disagrees and thinks LP and her Global Force are doing great dealing with the adversity of running a trial amid new discoveries about pseudo progression.
You are totally wrong iclight. I believe the other way around. This time NWBO needs Sawston/Advent to progress to meet objectives to bring treatment to patients. They are the workhorse if you will to get to the destination. Why selling the workhorse? If NWBO wanted to meet its objectives, keep the workhorse ready and happy.